In a grab-bag settlement with the HHS Office of Inspector General (OIG), a private molecular information corporation in Arizona agreed to pay $3.43 million to settle allegations that it overbilled Medicare for genetic testing, waived patient copays and paid various kickbacks to physicians and a clinical decision support software manufacturer for patient referrals. It’s unusual to see so many seemingly unrelated items in the same settlement, attorneys said. It makes sense, however, for organizations to put all known compliance concerns in a self-disclosure where possible, said Private Equity partner Asher Funk in Washington, D.C. “You don’t want to disclose only one issue when a bunch of other concerns are hanging out there,” Funk said, while speaking with the RMC. It’s much better “to put everything on the table in an effort to reach a global resolution.”